Table 2. Clinical characteristics of remission patients who underwent retreatment (n = 16).
| Relapse | Remission | |
|---|---|---|
| Pulmonary Symptoms | ||
| Cough | 16 | 0 |
| Wheeze | 12 | 2 |
| Shortness of breath | 9 | 1 |
| Comorbid Symptoms | ||
| Fever | 4 | 0 |
| Fatigue | 10 | 1 |
| Organ involvement | 5 | 0 |
| HRCT Lesions | ||
| Symmetrical/Unilateral | 11/5 | 2/1 |
| Hilar/Field | 16/12 | 8/4 |
| Nodular/Pathy/Opaque | 14/5/5 | 4/1/1 |
| Scattered/Multiple | 10/6 | 2/2 |
| Laboratory Tests | ||
| ESR elevated | 13 | 3 |
| hsCRP elevated | 7 | 0 |
| Serum ACE elevated | 5 | 0 |
| Pulmonary Function Tests | ||
| Reduced FEV1% | 6 | 0 |
| Reduced DLco% | 8 | 0 |
ESR elevated: above 15 mm/h in males and above 20 mm/h in females; hsCRP elevated: above 3.0 mg/l; serum ACE elevated: above 62 U/ml. Reduced FEV1 and DLco% were below 80 percent of the predicted values.